Description

Insulin Lispro (5.97 Mg) is a rapid-acting insulin analog engineered for improved pharmacokinetic properties. This product is critical for providing a fast-acting therapeutic option in the management of diabetes, offering patients greater flexibility in meal timing. It is primarily required by pharmaceutical manufacturers and research institutions developing advanced diabetes treatments and delivery systems.

Application

• Active Pharmaceutical Ingredient (API) in rapid-acting insulin formulations for diabetes treatment.
• Key component in pre-filled insulin pens and cartridges for subcutaneous injection.
• Research and development of novel insulin delivery mechanisms, including pumps and closed-loop systems.
• Manufacturing of combination therapies with other long-acting insulin analogs.
• Use in clinical studies and bioequivalence testing for generic drug development.
• Production of lyophilized (freeze-dried) insulin products for enhanced stability.

Basic Information

Product Name	Insulin Lispro (5.97 Mg)
CAS No.	133107-64-9
Molecular Formula	C257H383N65O77S6
Molecular Weight	5807.6 g/mol (monomer)
Synonyms	Insulin Lispro; Lys(B28), Pro(B29)-human insulin; Humalog; LY275585; Insulin analog lispro; Lispro insulin; Insulin (human) Lys(B28) Pro(B29); Insulin lispro rDNA origin
EINECS	Contact for details

Quality Control

Our Insulin Lispro is manufactured under strict quality systems suitable for pharmaceutical applications. Each batch is tested to ensure compliance with relevant pharmacopeial standards (e.g., USP, EP) for identity, purity, potency, and biological activity. Certificates of Analysis (COA) detailing comprehensive test results, including HPLC purity, peptide mapping, and bioassay data, are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature 15-25°C (59-77°F) or under refrigerated conditions at 2-8°C (36-46°F) as specified. This material is hygroscopic (moisture-sensitive) and must be kept in a dry environment to maintain stability and potency.

Specification

Item	Specification
Appearance	White or almost white powder
Identification (HPLC)	Conforms to reference standard
Identification (Peptide Map)	Conforms
Assay (HPLC)	95.0% - 105.0%
Related Proteins (HPLC)	NMT 3.0%
High Molecular Weight Proteins (SEC-HPLC)	NMT 1.0%
Zinc Content	Contact for details
Water Content (KF)	NMT 10.0%
Biological Potency	27.5 - 32.5 IU/mg
Bacterial Endotoxins	< 10 EU/mg
Sterility (if supplied sterile)	Sterile

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.